Chen Zhiyang, Hu Min
Department of Laboratory Medicine, The Second Xiangya Hospital of Central South University, Changsha, PR China.
Department of Laboratory Medicine, The Second Xiangya Hospital of Central South University, Changsha, PR China.
Clin Chim Acta. 2020 Dec;511:235-242. doi: 10.1016/j.cca.2020.10.023. Epub 2020 Oct 21.
Liver dysfunction is always accompanied by lipid metabolism dysfunction. Apolipoprotein M (apoM), a member of the apolipoprotein family, is primarily expressed and secreted from the liver. apoM is the main chaperone of sphingosine-1-phosphate (S1P), a small signalling molecule associated with numerous physiologic and pathophysiologic processes. In addition to transport, apoM also influences the biologic effects of S1P. Most recently, numerous studies have investigated the potential role of the apoM-S1P axis in a variety of hepatic diseases. These include liver fibrosis, viral hepatitis B and C infection, hepatobiliary disease, non-alcoholic and alcoholic steatohepatitis, acute liver injury and hepatocellular carcinoma. In this review, the roles of apoM and S1P in the development of hepatic diseases are summarized, and novel insights into the diagnosis and treatment of hepatic diseases are discussed.
肝功能障碍总是伴随着脂质代谢功能障碍。载脂蛋白M(apoM)是载脂蛋白家族的成员之一,主要在肝脏中表达和分泌。apoM是鞘氨醇-1-磷酸(S1P)的主要伴侣蛋白,S1P是一种与众多生理和病理生理过程相关的小信号分子。除了运输功能外,apoM还影响S1P的生物学效应。最近,大量研究探讨了apoM-S1P轴在多种肝脏疾病中的潜在作用。这些疾病包括肝纤维化、乙型和丙型病毒性肝炎感染、肝胆疾病、非酒精性和酒精性脂肪性肝炎、急性肝损伤和肝细胞癌。在这篇综述中,总结了apoM和S1P在肝脏疾病发生发展中的作用,并讨论了对肝脏疾病诊断和治疗的新见解。